Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.
Santini G, Coser P, Congiu AM, Salvagno L, De Souza C, Sertoli MR, Olivieri A, Chisesi T, Rubagotti A, Truini M, Contu A, Porcellini A, Zambaldi G, Nati S, Marino G, Rizzoli V. Santini G, et al. Among authors: rizzoli v. Haematologica. 2000 Feb;85(2):160-6. Haematologica. 2000. PMID: 10681723 Clinical Trial.
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
Santini G, Salvagno L, Leoni P, Chisesi T, De Souza C, Sertoli MR, Rubagotti A, Congiu AM, Centurioni R, Olivieri A, Tedeschi L, Vespignani M, Nati S, Soracco M, Porcellini A, Contu A, Guarnaccia C, Pescosta N, Majolino I, Spriano M, Vimercati R, Rossi E, Zambaldi G, Mangoni L, Rizzoli V, et al. Santini G, et al. Among authors: rizzoli v. J Clin Oncol. 1998 Aug;16(8):2796-802. doi: 10.1200/JCO.1998.16.8.2796. J Clin Oncol. 1998. PMID: 9704732 Clinical Trial.
Cemp, a mitoxantrone containing combination, in the treatment of intermediate and high grade non-hodgkin's lymphoma: an effective and non toxic therapeutic alternative for adult and elderly patients.
Chisesi T, Polistena P, Contu A, Coser P, Indrizzi L, Leoni P, Majolino I, Porcellini A, Salvagno L, Zambaldi G, Rizzoli V, Congiu AM, Santini G; Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). Chisesi T, et al. Among authors: rizzoli v. Leuk Lymphoma. 2001 Mar;41(1-2):125-36. doi: 10.3109/10428190109057961. Leuk Lymphoma. 2001. PMID: 11342364 Clinical Trial.
Fludarabine, cyclophosphamide and mitoxantrone for untreated follicular lymphoma: a report from the non-Hodgkin's lymphoma co-operative study group.
Santini G, Chisesi T, Nati S, Porcellini A, Zoli V, Rizzoli V, Zupo S, Marino G, Rubagotti A, Polacco A, Spriano M, Vimercati R, Congiu AM, Ravetti JL, Aversa S, Candela M, Patti C. Santini G, et al. Among authors: rizzoli v. Leuk Lymphoma. 2004 Jun;45(6):1141-7. doi: 10.1080/10428190310001623874. Leuk Lymphoma. 2004. PMID: 15359993
Autologous bone marrow transplantation (ABMT) in poor prognosis diffuse non-Hodgkin's lymphomas (NHL). Report of Non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
Coser P, Santini G, Rizzoli V, Porcellini A, Chisesi T, Sertoli R, Contu A, Salvagno L, Vinante O, Rossi E, et al. Coser P, et al. Among authors: rizzoli v. Bone Marrow Transplant. 1989 Dec;4 Suppl 4:164. Bone Marrow Transplant. 1989. PMID: 2697432 Clinical Trial. No abstract available.
Impact of interferon at induction chemotherapy and maintenance treatment for multiple myeloma. Preliminary results of a multicenter study by the Italian non-Hodgkin's Lymphoma Cooperative Study Group (NHLCSG).
Capnist G, Vespignani M, Spriano M, Damasio E, Craviotto L, Rizzoli V, Contu A, Olmeo N, Tedeschi L, Fabris P, et al. Capnist G, et al. Among authors: rizzoli v. Acta Oncol. 1994;33(5):527-9. doi: 10.3109/02841869409083930. Acta Oncol. 1994. PMID: 7522487 Clinical Trial.
Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G. Carlo-Stella C, et al. Among authors: rizzoli v. Haematologica. 1997 May-Jun;82(3):291-6. Haematologica. 1997. PMID: 9234574 Clinical Trial.
199 results